[HTML][HTML] Emerging trends in poly (lactic-co-glycolic) acid bionanoarchitectures and applications
CI Idumah - Cleaner Materials, 2022 - Elsevier
Abstract Recently, Poly (lactic-co-glycolic) Acid (PLGA) has garnered great attention as
foundational material for biomedical applications due to inherent biocompatibility, and …
foundational material for biomedical applications due to inherent biocompatibility, and …
Options of therapeutics and novel delivery systems of drugs for the treatment of melanoma
Melanoma is one of the most severe cancerous diseases. The cells employ multiple
signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell …
signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell …
Revitalizing Cytokine‐Based Cancer Immunotherapy through Advanced Delivery Systems
Cytokines can coordinate robust immune responses, holding great promise as therapeutics
against infections, autoimmune diseases, and cancers. In cancer treatment, numerous pro …
against infections, autoimmune diseases, and cancers. In cancer treatment, numerous pro …
Application of nanomedicines in tumor immunotherapy
Z Gao, D Wan, M Luo, X Wei - Journal of Molecular Cell Biology, 2024 - academic.oup.com
Tumor immunotherapy has emerged as a formidable strategy, demonstrating substantial
achievements in the field of cancer treatment. Despite its remarkable success, intrinsic …
achievements in the field of cancer treatment. Despite its remarkable success, intrinsic …
[HTML][HTML] Nanosphere pharmacodynamics improves safety of immunostimulatory cytokine therapy
RA Lacinski, SA Dziadowicz, A Stewart… - Iscience, 2024 - cell.com
Systemic administration of interleukin (IL)-12 induces potent anti-tumor immune responses
in preclinical cancer models through the systemic activation of effector immune cells and …
in preclinical cancer models through the systemic activation of effector immune cells and …
Optimizing the synthesis of interleukin‐12‐loaded PLGA nanospheres (rmIL‐12ns) via ultrasonication for treatment of metastatic osteosarcoma
RA Lacinski, JE Markel, HG Pratt… - Journal of …, 2023 - Wiley Online Library
Clinical trials exploring bolus intravenous delivery of interleukin‐12 (IL‐12) for treatment of
solid tumors ultimately failed due to lack of clinical response and severe dose‐limiting …
solid tumors ultimately failed due to lack of clinical response and severe dose‐limiting …
Advances in engineering and delivery strategies for cytokine immunotherapy
M Bohmer, Y Xue, K Jankovic… - Expert opinion on drug …, 2023 - Taylor & Francis
Introduction Cytokine immunotherapy is a growing field for the treatment of cancer, infectious
disease, autoimmunity, and other ailments. Therapeutic cytokines are a class of secreted …
disease, autoimmunity, and other ailments. Therapeutic cytokines are a class of secreted …